Effect of Alogliptin/Pioglitazone on the Preservation of Long-term Beta-cell Function After Early Intensive Diabetes Treatment
Phase of Trial: Phase IV
Latest Information Update: 27 Jul 2017
At a glance
- Drugs Alogliptin/pioglitazone (Primary) ; Glimepiride/metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 21 Jul 2017 Planned End Date changed from 1 Aug 2020 to 1 Dec 2021.
- 21 Jul 2017 Planned primary completion date changed from 1 Aug 2020 to 1 Jul 2021.
- 21 Jul 2017 Status changed from not yet recruiting to recruiting.